3702 related articles for article (PubMed ID: 6982444)
1. The role of cytotoxic T lymphocytes in the pathogenesis of Vogt-Koyanagi-Harada disease.
Maezawa N; Yano A; Taniguchi M; Kojima S
Ophthalmologica; 1982; 185(3):179-86. PubMed ID: 6982444
[TBL] [Abstract][Full Text] [Related]
2. Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt-Koyanagi-Harada disease that recognize human melanoma cells.
Maezawa N; Yano A
Microbiol Immunol; 1984; 28(2):219-31. PubMed ID: 6203018
[TBL] [Abstract][Full Text] [Related]
3. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Aosai F; Segawa K
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1210-6. PubMed ID: 2142146
[TBL] [Abstract][Full Text] [Related]
4. Vogt-Koyanagi-Harada syndrome--isolation of cloned T cells with specificity for melanocytes and melanoma cells.
McClellan KA; MacDonald M; Hersey P; Billson FA
Aust N Z J Ophthalmol; 1989 Nov; 17(4):347-52. PubMed ID: 2624724
[TBL] [Abstract][Full Text] [Related]
5. [Existence of cytotoxic T lymphocytes specific for human melanoma cells in Vogt-Koyanagi-Harada disease (author's transl)].
Maezawa N
Nippon Ganka Gakkai Zasshi; 1981 Sep; 85(9):1406-11. PubMed ID: 6976680
[No Abstract] [Full Text] [Related]
6. Requirement of Ia-positive nylon wool adherent cells for activation of cytotoxic T-lymphocytes specific to melanocyte-associated antigens in patients with Vogt-Koyanage-Harada's disease.
Maezawa N; Yano A
Jpn J Ophthalmol; 1988; 32(3):348-57. PubMed ID: 3265967
[TBL] [Abstract][Full Text] [Related]
7. Surface markers of peripheral blood lymphocytes in Vogt-Koyanagi-Harada disease.
Okubo K; Kurimoto S; Okubo K; Matsumoto K; Yokoyama MM
J Clin Lab Immunol; 1985 May; 17(1):49-52. PubMed ID: 3840207
[TBL] [Abstract][Full Text] [Related]
8. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.
Norose K; Yano A
Br J Ophthalmol; 1996 Nov; 80(11):1002-8. PubMed ID: 8976730
[TBL] [Abstract][Full Text] [Related]
9. [Involvement of Ia-positive accessory cells for activation of cytotoxic T lymphocyte specific for melanocyte-associated antigens in patients with Vogt-Koyanagi-Harada disease].
Maezawa N; Tsukahara S
Nippon Ganka Gakkai Zasshi; 1985 Mar; 89(3):440-6. PubMed ID: 3874531
[No Abstract] [Full Text] [Related]
10. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
11. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus.
Inomata H; Sakamoto T
Curr Eye Res; 1990; 9 Suppl():35-40. PubMed ID: 1974489
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo in Vogt-Koyanagi-Harada disease: immunohistological analysis of inflammatory site.
Okada T; Sakamoto T; Ishibashi T; Inomata H
Graefes Arch Clin Exp Ophthalmol; 1996 Jun; 234(6):359-63. PubMed ID: 8738701
[TBL] [Abstract][Full Text] [Related]
14. [Antibody-dependent cell-mediated cytotoxicity (ADCC) against melanocyte antigens in Vogt-Koyanagi-Harada disease (author's transl)].
Tagawa Y; Sugiura S
Nippon Ganka Gakkai Zasshi; 1977 Aug; 81(8):1101-4. PubMed ID: 930771
[No Abstract] [Full Text] [Related]
15. [Lymphocyte subsets and interleukin-2 (IL-2) production of peripheral blood lymphocytes in patients with Vogt-Koyanagi-Harada disease].
Iwata M; Kitano S; Sawada S; Nishinarita S
Nippon Ganka Gakkai Zasshi; 1989 Nov; 93(11):1025-31. PubMed ID: 2513711
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis.
Yokoyama MM; Matsui Y; Yamashiroya HM; O'Donnell MJ; Tseng CH; Snyder DA; Tessler HH; Crispen RG; Zimjewski CM
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):364-70. PubMed ID: 7203881
[TBL] [Abstract][Full Text] [Related]
17. [Lymphocyte subsets in peripheral blood and cerebrospinal fluid in Vogt-Koyanagi-Harada disease].
Kuwasaki N; Shoji H; Kaji M; Matsumoto K; Yokoyama M
Rinsho Shinkeigaku; 1985 Aug; 25(8):956-9. PubMed ID: 4064437
[No Abstract] [Full Text] [Related]
18. Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma.
Crosson JN; Laird PW; Debiec M; Bergstrom CS; Lawson DH; Yeh S
J Immunother; 2015; 38(2):80-4. PubMed ID: 25658618
[TBL] [Abstract][Full Text] [Related]
19. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.
Damico FM; Cunha-Neto E; Goldberg AC; Iwai LK; Marin ML; Hammer J; Kalil J; Yamamoto JH
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2465-71. PubMed ID: 15980237
[TBL] [Abstract][Full Text] [Related]
20. [Surface marker studies of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada diseases].
Okubo K; Kurimoto S; Okubo K; Yokoyama MM
Nippon Ganka Gakkai Zasshi; 1985 Jun; 89(6):726-32. PubMed ID: 3877406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
